CXCL9 plays a key role in inflammation, collagen deposition, and tissue remodeling and is involved in the pathogenesis and complications of MASLD (Figure 1A) (52). This evidence concerns the gene CXCL9 and metabolic dysfunction-associated steatotic liver disease.